Omada Health Surpasses 1 Million Members, Expands GLP-1 Access with PBM Partnerships
Event summary
- Omada Health reported Q1 2026 revenue of $78 million, up 42% year-over-year.
- Total members surpassed 1 million, a 51% year-over-year increase.
- Omada now partners with all three of the nation’s leading PBMs, including Optum Rx.
- Clinical analysis shows members in the GLP-1 Care Track lost 1.8 times the total weight compared to a control group.
- Omada will serve as an independent program administrator in Eli Lilly’s Employer Connect program.
The big picture
Omada Health’s milestone of surpassing 1 million members underscores its role as a key player in virtual care for cardiometabolic conditions. The company’s strategic partnerships with leading PBMs and Eli Lilly position it to capitalize on the growing demand for GLP-1 therapies and digital health solutions. As the healthcare industry shifts towards more integrated, virtual-first models, Omada’s ability to deliver measurable clinical outcomes will be critical to its long-term success.
What we're watching
- Market Expansion
- How Omada’s partnerships with all three leading PBMs will affect its market penetration and revenue growth.
- Clinical Efficacy
- Whether the clinical outcomes of the GLP-1 Care Track can sustain long-term member engagement and retention.
- Financial Performance
- The pace at which Omada can achieve profitability given its current growth trajectory and operational leverage.
Related topics